GB2028331A - A process for the activation of carboxylic acids - Google Patents

A process for the activation of carboxylic acids Download PDF

Info

Publication number
GB2028331A
GB2028331A GB7922875A GB7922875A GB2028331A GB 2028331 A GB2028331 A GB 2028331A GB 7922875 A GB7922875 A GB 7922875A GB 7922875 A GB7922875 A GB 7922875A GB 2028331 A GB2028331 A GB 2028331A
Authority
GB
United Kingdom
Prior art keywords
acid
added
salt
carboxylic acid
methylene chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB7922875A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antibioticos SA
Original Assignee
Antibioticos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antibioticos SA filed Critical Antibioticos SA
Publication of GB2028331A publication Critical patent/GB2028331A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings

Abstract

A process for the activation of carboxylic acids which is useful for the subsequent conversion of said carboxylic acids into their corresponding amides or esters, based on reacting a 2-oxazolidinone with phosphorus pentachloride to give a compound of the formula <IMAGE> where R1 and R2 are H or C1-4 alkyl; then a salt of the carboxylic acid to be activated is added and the reaction mixture is treated with a compound having an amine or hydroxyl function to give an amide or an ester.

Description

SPECIFICATION A process for the activation of carboxylic acids The invention relates to a process for the activation of carboxylic acids which is useful for the subsequent conversion of said carboxylic acids into their corresponding amides or esters.
The process is based on the reaction of said acids with P-trichlorinated N,N' - bis - (3 - oxazolydinyl - 2 one) phosphoranes.
These new phosphorus compounds respond to the following general formula
in which R1 and Rz may be atoms of hydrogen or alkyl groups having from one to four carbon atoms and X1, X2 and X3 are preferably chlorine or any substituent introduced by nucleophilic substitution thereof, such as: bromine, cyano, iodine, do methyl formamide, dimethylacetamide, etc. When X1 = X2 = X3 = Cl,thecompounds respond to the following general formula:
in which R, and R2 are as defined hereinabove.
In order to simplify the notation of the 2 oxazolidinone groups, they will be abbreviated with the letters OXA, the compounds of the general formula la, object of the invention, derived from the general formula I, being represented by the following expression to which reference may be made: (OXA)2 - P - (Cl)3 The process of the invention is characterised fundamentally by comprising the following steps:: a) reacting one equivalent of a 2 - oxazolidinone of the general formula
in which R1 and R2 are a group selected from among hydrogen and alkyl groups having from one to four carbon atoms, in an inert solvent with at least one half equivalent of phosphorus pentacloride, at a temperature lying between -15"C and + 1 000C, to give P - trichlorinated N,N' - bis - 3(oxazolydinyl - 2 one) phosphoranes of the formula
in which R1 and R2 are likewise a group selected from among hydrogen and alkyl groups having from one to four carbon atoms;; b) adding thereafter a salt of the carboxylic acid to be activated, and c) treating the mixture resulting from the activation reaction with a compound of the group comprising compounds with an amine function and compounds with hydroxyl function, to produce an amide or an ester, respectively.
According to a further feature of the invention, R1 and R2 are hydrogen and the carboxylic acid salt is a tertiary organic base salt.
According to yet a further feature of the invention, R1 and R2 are hydrogen; the salt of the carboxylic acid to be activated is a triethylamine salt; and the compound with amine function is selected from among the group including 6 - aminopenicillanic acid, 7 - aminocephalosporanic acid, 7 aminodesacetoxycephalosporanic acid, 3 - su bstituted 7 - amino - 83 - cephem - 4 - carboxylic acid and their corresponding esters.
Preferably, according to the invention, one of the compounds from the group comprising methylene chloride, chloroform, nitromethane and acetonitrile is used as inert solvent, either alone, or in combination.
The interest of these new formula I compounds is based on the fact that their surprising capacity to activate the carboxylic acid and amine functions has just been discovered and they are, therefore, valuable reactants reagents in synthesis applied to industrial processes, an example thereof being the fields of penicillins, cephalosporins, esters of therapeutical value in human and veterinary medicine, etc.
The said family of formula I compounds is prepared by the sequence shown in Scheme A via two alternative routes, differing from one another in the isolation of the N - trichlorophosphonium - 2 oxazolidinone or the direct use with two moles of OXA for one of phosphorus pentachloride. SCHEME A
where Nu is a nucieophilic substituent.
One practical way of preparing (OXA)2 - P - (Cl)3 comprises reacting a solution of two equivalents of 2 - oxazolidinone with one mole of phosphorus pentachloride in an inert solvent, conducting the reaction at room temperature (20-25"C) for 24 hours. A particularly appropriate solvent is methylene chloride. Thereafter, the solvent is driven off at reduced pressure to give (OXA)2 - P - (Cl)3 with a virtually quantitative yield. In all cases, it is advisable to operate under strictly an hydros conditions.
In view of the characteristics of the formula I compounds, their "in situ" preparation is recommended.
All these compounds are potential, highly effective reactants, the results of which are reflected in Scheme B. To facilitate the understanding of the matter, this Scheme will be limited to the (OXA)2 - P (Cl)3 of formula la, although the results given here are extrapolatable to the remaining formula I compounds.
SCHEME B a) Reaction with carboxylic acids
the Figures in brackets ( ) indicate the number of reacting or resulting equivalents.
In certain cases, the formation of the 2 ester of oxazolidinone, also a reactive compound (Spanish patent no 444.470) is detected.
If one chlorine atom in the (OXA)3 - P - (Cl)3 is substituted by a dimethylformamide type nucleophilic substituent, the second stage is made impossible and constitutes a new process for the preparation of acid chlorides.
b) Reaction with amines: Amides may also be prepared by previously activating the amine function and then adding the carboxylic acid. The reaction may possibly take place through the formation of a - P = N -. In this case, the yields are inferior to those obtained in a).
To sum up, it may be said that it is possible to activate 2 moles of carboxylic acid, one in the form of acid chloride and the other in the form of acyloxphosphoramide, with one mole of formula la compound.
One of the desirable ways of conducting the process in practice, consists of adding a solution of the triethylamine salt of the carboxylic acid over a suspension containing the compound to be acylated with triethylamine, which acts as acceptor of the protons released.
It has been confirmed thatfor the object of the invention no limitations or exceptions for the reaction between a carboxylic acid salt and (OXA)2 - P (Cl)3, the following compounds having shown themselves to be usable: 2 - thienylacetic acid, 3 thienylacetic acid, cyanacetic acid, 4 - pyridinmercaptoacetic acid, 1 - (H) - tetrazolylacetic acid, alpha formyloxyphenylacetic acid, alpha - methoxyimino 2 - furylacetic acid, trifluoromethyl - mercaptoacetic acid, mandilic acid, monophenyl phenyl - malonate, mono -5 - indamyl phenylmalonate, alpha azidophenyl acetic acid, 3(2 - chlorophenyl) - 5 methyl - isoxazolyl - 4 - carboxylic acid, 3(2,6 - dich lorophenyl) - 5 - methyl - isoxazolyl - 4 - carboxylic acid, 3(2,6 - chloro - fluorophenyl) - 5 - methyl - isoxazolyl - 4 - carboxylic acid, phenylisoxazolylcarboxylic acid, cyclohexadinylacetic acid, methoxyacetic acid, 4 - methyl - 1,2,5 - oxadiazolyl - 3 - acetic acid, methylmercaptoacetic acid, alpha - sulphophenylace tic acid, monophenyl 2 - thienylmalonate, cyanomethylmercaptoacetic acid, alpha - sulphoisobutoxyphenylacetic acid. In general, acids with an aromatic ring, such as phenyl, naphthyl, tolyl, xylyl, mesityl or heterocylic groups with one or various heteroatoms such as furane, thiophen, pyrrol, pyrazole, oxadiazole, thiatriazole, imidazole, triazole, thiazole, isodiazole, oxazole, isoxazole, thiadiazole, oxatriazole, tetrazole, pyridine, pyrazine, pyrimidine, pyridazine, benzothiophen, ben zofurane, indole, indazole, benzoimidazole, ben- zothiazole, benzothiadiazole, benzoxazole, quinoline, isoquinoline, quinoxaline, quinazoline, imidazolidine, among others, may be used.The aliphatic, aromatic, heterocyclic residue of these acids may support one or several substituents such as, for example, the halogens, hydroxy, mercapto, carboxyl, alkyl, alkoxy, alkylthio, nitro, sulfo, alkylamino, dialkylamino, cyano, arylcarbonyloxy, arylalkanoyloxy. When the substituents are hydroxy, carboxy and amino, they have a protector group which is eliminated by applying the usual methods.
The preferred organic bases are the tertiary bases which may also be used in the form of salts of weak acids, such a pivalic acid or 2 - ethylhexanoic acid, of triethylamine, tributylamine, tripropylamine, picolines, lutidines, cholidines, quinoleins, dimethylaniline and diethylaniline. Nevertheless, the low industrial cost ones are chosen which are easy to eliminate so as to facilitate the isolation of the pure amide or ester.
The amino function compounds which are useful for the invention have not shown any limitations, both with the sterically hindered ones and with those of lower basicity belonging to the aromatic series. As was to be expected, there have been no difficulties with the aliphatic ones and in particular the heterobicyclic ones such as the 6 - aminopenicillanic acids (6 - APA) and the 7 - aminocephalosporanic acids (7 - ACA) are of great interest. In these cases, the carboxyl function is found in the form of salt of triethylamine, diethylamine, morpholine and dicyclohexylamine, or as a silyl, benzyl, phenacyl, phthalidic, trichloroethylester or aldehyde gemhydroxyl semi - esters, namely, gem - diacycloxy derivative of aldehydes.
The C - 3' substituents of the 7 - aminocephalosporanic acids may be selected from among the group comprising, methyl, acyloxymethyl, alkoxymethyl, formyl, azidomethyl, chloromethyl, formylidene alkyl amino, 5 - tertbutoxycar bonylaminomethyl - 1,3,4 - thiadiazolyl - 2 - mercaptomethyl, 5 - aminomethyl - 1,3,4 - thiadiazolyl - 2 mercaptomethyl, 5(3- methylureidomethyl) -1,3,4thiadiazolyl - 2 - mercaptomethyl, carbamoyloxymethyl alpha - methoxy- p- sulphoxy- cinnamoyloxymethyl chlorine and 1 - sulphomethyltet razolyl - 5 - mercaptomethyl, among other similar heterocyclic groups such as pyridiminomethyl and pyrimidiniummethyl.
The amino function may be linked with a nitrogen atom with or without substituents, in the case ofhydrazine, phenylhydrazine and the like, with the process following under identical conditions.
The combination with the (OXA)2 - P - (Cl)3 is conducted in an inert solvent which is not critical forthe performance of the process. Of particular interest are methylene chloride or mixtures thereof with nitromethane. Another appropriate binary system is methylene chloride/acetonitrile. The reaction of the (OXA)2 - P - (Cl)3 with the organic acid salt is effected at a temperature lying between -20 and +20"C, with stirring over a period of time ranging from 30 to 150 minutes. A solution containing the amine, the alcohol and triethylamine or an acceptor of the released protons is added to the solution or suspension containing the activated acid.
It should also be observed that the (OXA)2 - P - (Cl)3 reacts with alcohols and water in accordance with Scheme C.
SCHEME C
to produce N,N' - bis - (3 - oxazolydinyl - 2 - one) chlorophosphoramide.
To facilitate the understanding of the foregoing ideas, there are described hereinafter certain examples of the practice of the invention which, in view of their purely illustrative nature, must be considered to be lacking in any limitative effect on the scope of the legal protection being applied for.
EXAMPLE 1 Preparation of P - trichlorinated N,N' - bis - (3- oxazolydinyl - 2 - one) phosphorane.
1.8 g (2 cmoles) of 2 - oxazolidinone were dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride were added.
The mixture was stirred for 24 hours at room temperature. The mixture was degassed at reduced pressure to give the compound of the title with a quantitative yield. Thereafter methylene chloride was added up to the initial volume.
The l.R. spectrum obtained of a solution in methylene chloride shows a carbonyl band at 1780 cm~', without there being any reading at 1760 cm-' corresponding to the 2 -* oxazolidinone.
EXAMPLE2 Preparation ofP - trichlorinated -N,N' - bis - (3- oxazolydinyl - 2 - one) phosphorane.
Following Example 1 but replacing the methylene chloride with acetonitrile and stirring for 35 hours at room temperature, the compound of the title was obtained, also with quantitative yield.
EXAMPLE3 Preparation of P- trichlorinated N,N'- bis - (3- oxazolydinyl - 2 - one) phosphorane.
1.8 g (2 cmoles) of 2 - oxazolidinone were dissolved in 20 ml of nitromethane, the mixture was cooled to 0-5"C and the phosphorus pentachloride was added. The mixture was allowed to reach room temperature and was stirred for 30 hours. It was degassed under reduced pressure to give the compound of the title with quantitative yield.
EXAMPLE4 Preparation ofP- trichlorinated N,N'- bis - (3 - oxazolydinyl - 2 - one) phosphorane.
0.871 g (1 cmole) of 2 - oxazolidinone was dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride were added. A very abundant solid precipitated out in a few minutes. It was stirred for 15 minutes and 0.871 g (1 cmole) of 2 - oxazolidinone was added. The mixture was held under refluxfor 13 hours to give the compound of the title with a quantitative yield.
EXAMPLE 5 Preparation ofP- trichiorinated N, N'- bis - (3 - oxazolydinyl - 2 - one) phosphorane.
Following Example 3 but replacing the nitromethane with a mixture of nitromethane and methylene chloride the compound of the title was obtained with a quantitative yield.
EXAMPLE 6 Preparation of P- trichlorinated N,N'- bis - (3 oxazolydinyl - 2 - oneJ phosphorane.
Following Example 1 but replacing the methylene chloride with chloroform the compound of the title was obtained with a quantitative yield.
EXAMPLE 7 Benzoic acid anilide.
1.8 g (2cmoles) of 2 - oxazolidinone were dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride were added.
The mixture was stirred at room temperature for 24 hours. It was then degassed at reduced pressure and methylene chloride then being added up to the original volume. Thereafter a solution of 1.94 g (1.6 cmoles) of benzoic acid and 2.3 ml of triethylamine in 15 ml of methylene chloride were added. The mixture was stirred at room temperature until a solution was formed. A solution of 2 ml of aniline and 2.3 ml of triethylamine in 5 ml of methylene chloride was added. The mixture was stirred at room temperature for 3 hours. 20 ml of water were added and the pH was adjusted to approximately 1 by the addition of hydrochloric acid. The organic phase was extracted and washed twice with 20 ml of water, was dried over anhydrous sodium sulphate and dried. A crystalline pink solid was obtained.Methanol was added, partially dissolving the solid and thereafter water was added to produce an abundant crystalline solid.
This was filtered, washed with methanol to give 2.8 g of benzyl anilide (yield 90%).
EXAMPLE 8 2 - thienylacetic acid aniline.
Following Example 7 but replacing the benzoic acid with 2 - thienylacetic acid, 2.27 g (1,6 cmoles) the anilide was obtained with a 91% yield (3.185 g). EXAMPLE 9 Tetrazolylacetic acid anilide.
Following Example 7 but replacing the benzoic acid with tetrazolylacetic acid, (2.05 g) the anilide was obtained with a 92.6% yield (1.88 g).
EXAMPLE 10 Niflumic acid anilide (2- (3- trifluoromethyl - anilino) - nicotinic acid).
Following Example 7 but replacing the benzoic acid with niflumic acid, the anilide was obtained with a 92% yield, m.p. = 174"C. IR spectrum, amide band at 1640 cm-'.
EXAMPLE 11 Ethyl 1- (H) - tetrazolylacetate.
1.8 g (2 cmoles) of 2 - oxazolidinone were dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride were added.
The mixture was stirred at room temperature for 24 hours. It was degassed at reduced pressure, methylene chloride then being added up to the original volume. Thereafter a solution of 2.049 (1.6 cmoles) of 1 - (H) - tetrazolylacetic acid and 2.23 ml of triethylamine in 10 ml of methylene chloride was added. The mixture was stirred at room temperature until a solution was formed. 0.93 ml of ethanol was added and the mixture was stirred for 1 hour at room temperature. 10 ml of water were added, the organic phase was drawn off and was dried over anhydrous sodium sulphate. The solvent was driven off at reduced pressure to give 2.42 g of the ester.
Yield: 97%. IR spectrum: band at 1750 cm-'.
EXAMPLE 12 Phenyl benzoate Following Example 11 but replacing the 1 - (H) tetrazolylacetic acid with benzoic acid, 1.95 g (1.6 cmoles) and the ethanol with phenol, 1.51 g (1.6 cmoles) the ester of the title was obtained with a yield of 94% (2.98 g), m.p. = 68-70"C. IR spectrum: band at 1730 cm-'.
EXAMPLE 13 Methyl 3,5- dinitrobenzoate Following Example 11 but replacing the 1 - (H) tetrazolylacetic acid with 3,5 - dinitrobenzoic acid, 3.39 g (1.6 cmoles) and the ethanol with methanol, 0.64 ml (1.6 cmoles), the ester was obtained with a yield of 96% (2.17 g), m.p. = 108"C.
EXAMPLE 14 Methyl cyanacetate Following Example 11 but replacing the 1 - (H) tetrazolylacetic acid with cyanacetic acid, 1.62 g (1.6 cmoles) and the ethanol with methanol, the ester was obtained with a yield of 91% (1.05 g), m.p. = 200"C. Density: 1.0962.
EXAMPLE 15 6(3- (o - chlorophenyl) -5 - methyl - 4 - isoxazolylcarboxyamido) penicillanic acid sodium salt.
1.8 g (2 cmoles) of 2 - oxazolidinone were dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride were added.
The mixture was stirred at room temperature for 24 hours. It was degassed at reduced pressure, methylene chloridethen being added uptothe original volume. Thereafter, a solution of 3.8 g (1.6 cmoles) of 3 - (o - chlorophenyl) - 5 - methylisoxazol 4 - carboxylic acid and 2.3 ml of triethylamine in 20 ml of methylene chloride was added and the mixture was stirred at room temperature almost to solu tion. A solution of 3.469 g (1.6 cmole) of 6- aminopenicillanic acid and 5.6 ml of triethylamine in 20 ml of methylene chloride was prepared. Once solution had been obtained, 1.3 ml of 2 - ethylhexanoic acid were added to neutralise the excess triethylamine. This solution was cooled to -20 C and the first solution of 3 - (o - chlorophenyl) - 5 methylisoxazol - 4 - carboxylic acid was added thereto dropwise.The mixture was stirred at 0-5"C for 3 hours. 20 ml of water were added and the pH was adjusted to approximately 1 with hydrochloric acid. The organic phase was extracted and washed twice with 20 ml of water. It was dried over anhydrous sodium sulphate. The methylene chloride was concentrated at reduced pressure to a volume of approximately 50 ml; 20 ml of methylisobutylketone were added and thereafter 12 ml of 44% sodium 2 ethylhexanoate in methylisobutylketone diluted in 12 ml of methylisobutylketone were added dropwise. 300 ml of n - hexane were added dropwise with stirring, to give an abundant precipitate. This was filtered, washed with n - hexane to give 6 g of cloxacillin sodium (78.8%).
EXAMPLE 16 6(3- {2,6 - dichlorophenyl) - 5 - methylisoxazolyJ -4 - carboxyamido) - penicillanic acid sodium salt.
Following Example 15 but replacing the 3 - (o chlorophenyl) - 5 - methylisoxazol - 4 - carboxylic acid with 3 - (2,6 - dichlorophenyl) - 5- methylisoxazolyl - 4 - carboxylic acid, 6.6 g of dicloxacillin sodium with an 80.7% yield are obtained.
EXAMPLE 17 7 - (thienylacetamido) - cephalosporanic acid.
1.8 g (2 cmoles) of 2 - oxazolidinone were dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride were added.
The mixture was stirred at room temperature for 24 hours. It was degassed at reduced pressure, methylene chloride then being added up to the original volume.
Thereafter, a solution of 2.34 g of thienylacetic acid (1.6 cmole) and 2.3 ml of triethylamine in 20 ml of methylene chloride was added and the mixture was stirred at room temperature until almost solution. A solution of 4.849 (1.68 cmoles, 90 /O) of 7 aminocephalosporanic acid and 4.96 ml (3.54 cmoles) of triethylamine in 20 ml of methylene chloride was prepared. Once solution was obtained, there was added 2.83 ml of 2 - ethylhexanoic acid to neutralise the excess triethylamine. This solution was cooled to - 20 C and the first solution of thienylacetic acid was added thereto dropwise. A fair solution was produced. It was stirred at 0-5 C for 3l hours. 20 ml of water were added and the pH was adjusted to approximately 1 with hydrochloric acid.
A slightly turbid, pale brown organic phase was extracted. It was washed twice with 20 ml of water. It was dried over anhydrous sodium sulphate. The methylene chloride was concentrated at reduced pressure to a volume of approximately 50 ml; 20 ml of methylisobutylketone were added and a very abundant solid appeared. Itwas stirred and 12 mlof 44% sodium 2 - ethylhexanoate in methylisobutylketone diluted in 12 ml of methylisobutylketone were added dropwise. 60 ml of petroleum etherwere added, it was filtered and washed with petroleum ether to give 5.3 g of cephalothin sodium (79%) EXAMPLE 18 Alpha - carboxy - 5- indanyl- benzylpeniclllin.
Following Example 15, but replacing the 3 - (o chlorophenyl) - 5 - methylisoxazol - 4 - carboxylic acid with 3.936 g (1.6 cmoles) of phenylmalonic 5 indanyl hemiester, the sodium salt of the compound of the title was prepared with an 81.2% yield (6.06 g).
EXAMPLE 19 7 - cyanoacetamido cephalosporanic acid sodium salt.
Following Example 15 but replacing the 3 - (O chlorophenyl) - 5- methylisoxazol - 4- carboxylic acid with cyanacetic acid, 1.62 g (1.6 cmoles) and the 6 - aminopenicillanic acid with 7 - aminocephalosporanic acid, the sodium salt of the title was obtained with an 80% yield (3.41 g).
EXAMPLE 20 6 - (3- (2,6 - fluorchlorophenyl) -5 - methylisoxazol - 4 - carboxylic acid sodium salt.
Following Example 15, but replacing the 3 - (O chlorophenyl) - 5 - methylisoxazol - 4 - carboxylic acid with 3 - (2,6 - fluorchlorophenyl) - 5 methylisoxazol - 4- carboxylic acid, 4.088, (1.6 cmoles), the sodium salt penicillin was obtained with an 80% yield (6.09 g).
EXAMPLE2 1 D(-)phen ylglycine chloride hydrochloride.
5.4 g (6 cmoles) of 2 - pxazolidinone were dissolved in 60 ml of acetonitrile and 6.36 g (3 cmoles) of phosphorus pentachloride were added. The mixture was stirred for 24 hours at room temperature and 3.02 (2 cmoles) of D(-)phenylglycine were added without degassing to give a suspension which was stirred at room temperature for 3 hours.
It was filtered and washed with 80 ml of acetonitrile. The solid obtained was suspended in methylene chloride to remove the remains of chlorophosphoramide. 3.87 g of chloride hydrochloride were obtained in this way. Yield: 94% EXAMPLE 22 D(-)phenylglycine chloride hydrochloride.
5.4 g (6 cmoles) of 2 - oxazolidinone were dissolved in 60 ml of acetonitrile and 6.36 g (3 cmoles) of phosphorus pentachloride were added. The mixture was stirred for 24 hours at room temperature and was degassed at reduced pressure. 2.79 ml of dimethylacetamide were added dropwise and the mixture was stirred for 2 hours at room temperature.
Thereafter 3.02 g of D(-)phenylglycine were added and the above method was followed. Yield: 90%.
EXAMPLE 23 Benzoic acid anilide 1.8 g (2 cmoles) of 2 - oxazolidinone were dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride were added.
The mixture was stirred at room temperature for 24 hours. It was degassed at reduced pressure, methylene chloride then being added up to the original volume. It was cooled to -15 C and 0.8 mi (1 cmole) of dimethylformamide dissolved in 5 ml of methylene chloride was added dropwise. The mix ture was allowed to reach room temperature and was stirred for 1 hour, followed by the dropwise addition of a solution of 10 ml of methylene chloride, 2.1 ml of triethylamine and 1.22 g of benzoic acid.
The addition was made at -1 0 C and finally the mixture was stirred for 1 hour at room temperature. It was recooled to -100C and a solution of 10 ml of methylene chloride, 1.4 ml of triethylamine and 0.91 ml of aniline was added dropwise. From here Example 7 was followed to obtain the benzylanilide with a 95% yield.
EXAMPLE 24 2 - thienylacetic acid anilide Following Example 8 but replacing the 1.8 g of 2 oxazolidinone with 2.02 g of 4 - methyl - 2 oxazolidinone, the anilide was obtained with a 90% yield.
EXAMPLE 25 Phenyl benzoate Following Example 12 but replacing the 1.8 g of 2 oxazolidinone with 2.3 g of 5 - ethyl - 2 oxazolidinone, the ester was obtained with a 92% yield.
EXAMPLE 26 Sodium 7- (1 - (1H) - tetrazolylacetamidoJ dephalosporanate 1.8 g (2 cmoles) of 2 - oxazolidinone were dissolved in 20 ml of methylene chloride and 2.12 g (1 cmole) of phosphorus pentachloride was added. The mixture was stirred at 20-25"C for 24 hours. It was degassed at reduced pressure, methylene chloride then being added up to the original volume. Thereafter, a solution of 2.05 g (1.6 cmoles) of tetrazolylacetic acid and methylene chloride was added and the mixture was stirred at room temperature. A solution of 4.3 g (1.6 cmoles) of7 - aminocephalosporanic acid (7-ACA) dissolved in 30 ml of methylene chloride and 3.2 ml of triethylamine.It was cooled to -10 C and the activated acid was added, it was stirred for 2 hours at 0-5"C to give a pale yellow solution.
50 ml of an aqueous solution at pH 7 and simultaneously 1 N NaOH to hold the pH to 8-8.1 was added.
The solution was filtered and decanted. The water phase was extracted with a mixture of 70 ml of ethyl acetate and 30 ml of butanol, dropping the pH to 1.5-2. The organic extract was dried over anhydrous sodium sulphate and thereafter a solution of 20% sodium 2 - ethylhexanoate in methylisobutylketone was added dropwise. The corresponding sodium cephalosporin precipitated out with a 71% yield.
When the said cephalosporin is treated under normal conditions with 1,3,4 - thiadiazol - 2 - mercapto - 5 - methyl, 7 - (1 - (1 H) - tetrazolylacetamido) 3 - (5 - methyl - 1,3,4 - thiadiazolyl - 2 - thiomethyl) - A3 - cephem - 4- carboxylic acid is obtained.

Claims (6)

1. A process for the activation of carboxylic acids, useful for the subsequent conversion of said carboxylic acids into their corresponding esters or amides, wherein: a) one equivalent of a 2 - oxazolidinone of the gen eral formula
where R1 and R2 are a group selected from among hydrogen and alkyl groups having from one to four carbon atoms, is reacted in an inert solvent with at least one half equivalent of phosphorus pentach chloride at temperatures from -1 5"C to + 1 00 C to give P - trichlorinated N,N' - bis - 3(oxazolydinyl - 2 one) phosphoranes of the formula
where A1 and R2 are likewise a group selected from among hydrogen and alkyl groups having from one to four carbon atoms;; b) thereafter there is added a salt of the carboxylic acid to be activated, and c) the resulting activation reaction mixture is treated with a compound of the group comprising the compounds having an amine function and the compounds having a hydroxyl function, to give, respectively, an amide or an ester.
2. The process of claim 1, wherein R, and R2 are atoms of hydrogen and the carboxylic acid salt is a tertiary organic base salt.
3. The process of claim 1, wherein A1 and R2 are atoms of hydrogen; the salt of the carboxylic acid to be activated is a triethylamine salt; and the amine function compound is selected from among the group including 6 - aminopenicillanic acid, 7 aminocephalosporanic acid, 7 - aminodesacetoxycephalosporanic acid, 3 - substituted 7 - amino - A3 cephem - 4 - carboxylic acid and their corresponding esters.
4. The process of claim 1, wherein there is used as inert solvent one of the compounds of the group comprising methylene chloride, chloroform, nitromethane and acetonitrile either alone or in combination.
5. A process for the activation of carboxylic acids substantially as hereinbefore described.
6. Carboxylic acids whenever activated by the process claimed in any preceding claim.
GB7922875A 1978-07-15 1979-07-02 A process for the activation of carboxylic acids Withdrawn GB2028331A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES471783A ES471783A1 (en) 1978-07-15 1978-07-15 A process for the activation of carboxylic acids

Publications (1)

Publication Number Publication Date
GB2028331A true GB2028331A (en) 1980-03-05

Family

ID=8476492

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7922875A Withdrawn GB2028331A (en) 1978-07-15 1979-07-02 A process for the activation of carboxylic acids

Country Status (5)

Country Link
JP (1) JPS5533470A (en)
DE (1) DE2927536A1 (en)
ES (1) ES471783A1 (en)
FR (1) FR2430935A1 (en)
GB (1) GB2028331A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3140141A1 (en) * 1981-10-09 1983-04-28 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING AN AZOPIGMENT
JPS61159451A (en) * 1985-01-08 1986-07-19 Toshiba Silicone Co Ltd Polyorganosiloxane composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2234310A1 (en) * 1973-06-21 1975-01-17 Castro Bernard Azido-tris (dialkylamino) phosphonium salts - as peptide-coupling agents giving high yields
ES444470A1 (en) * 1976-01-20 1977-05-16 Gema S A Y Antibioticos S A Process of acilation of aminopenicilanic acids, aminocephalosporanicos, aminodesacetoxicefalosporanicos and derivatives. (Machine-translation by Google Translate, not legally binding)
ES461552A1 (en) * 1977-08-11 1978-06-01 Gema Sa P-Substituted N,N'-bis-(3-oxazolidinyl-2-one)phosphoramides and process for the preparation thereof

Also Published As

Publication number Publication date
JPS5533470A (en) 1980-03-08
JPH0129775B2 (en) 1989-06-14
DE2927536A1 (en) 1980-01-31
FR2430935A1 (en) 1980-02-08
ES471783A1 (en) 1979-10-16

Similar Documents

Publication Publication Date Title
US4410458A (en) Process for providing an oxidized penam
US4012382A (en) α-Amino and α-formyl-α-(p-acyloxyphenyl)acetamidocephalosporanic acid derivatives
US3767667A (en) Process for preparing 1h-tetrazole compounds
EP0082498B1 (en) Beta-lactam compounds and process for the preparation thereof
US4230849A (en) Process for the activation of carboxylic acids
US4145418A (en) Thienopyridine substituted cephalosporins
GB2028331A (en) A process for the activation of carboxylic acids
US4405782A (en) Process for the preparation of solutions of 7-aminocephalosporanic acids
EP0175814A2 (en) Process for preparing cephem derivatives
US4247461A (en) Esterification process using methoxymethyl-P-toluenesulfonate
US4145540A (en) 7β-Phosphoramido-7α-methoxycephalosporanic acid derivatives
US4393058A (en) Cephalosporin compounds
US3956287A (en) 7-[(2-Oxo-1-pyridinyl)acylamino]cephalosporin derivatives
EP0019067B1 (en) 5,10-dioxo-5,10-dihydrodiimidazo(1,5-a,1&#39;,5&#39;-d)pyrazine-1,6-dicarboxylic acid and a process for producing imidazoledicarboxylic acid amido-derivatives
EP0023045B1 (en) Imidazolecarboxylic acid derivatives of penicillins and cephalosporins
EP0045717B1 (en) New cephalosporin derivatives, their production and their use
US3956288A (en) 7-[(2,4-Dioxo-1-pyrimidinyl)acylamino]cephalosporin derivatives
CA1061330A (en) Process for the acylation of 6-aminopenicillanic (6-apa), 7-aminocephalosporanic (7-aca) and 7-aminodesacetoxycephalosporanic (7-adca) acids and their derivatives
JP2867438B2 (en) Method for producing cephalosporin compounds
US3704297A (en) 7 - (1,4 - cyclohexadienylacylamido)cephalosporanic acids and related compounds
US5585485A (en) Cephalosporin intermediate products
US3910900A (en) 7-(D-a-hydroxy-2-arylacetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US4008221A (en) 6-[(2,4-Dioxo-1-pyrimidinyl)acylamino]penicillin derivatives
US4003887A (en) Novel penicillins and their preparation
US4217275A (en) β-Lactam antibiotic esterification process using methoxymethyl methane sulfonate

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)